Differential effects of estrogen receptor antagonists on pituitary lactotroph proliferation and prolactin release
- 13 June 2005
- journal article
- Published by Elsevier in Molecular and Cellular Endocrinology
- Vol. 239 (1-2) , 27-36
- https://doi.org/10.1016/j.mce.2005.04.008
Abstract
No abstract availableKeywords
This publication has 45 references indexed in Scilit:
- Estrogen receptor β inhibits 17β-estradiol-stimulated proliferation of the breast cancer cell line T47DProceedings of the National Academy of Sciences, 2004
- Distinct Signaling Pathways Mediate Stimulation of Cell Cycle Progression and Prevention of Apoptotic Cell Death by Estrogen in Rat Pituitary Tumor PR1 CellsMolecular Biology of the Cell, 2003
- Tamoxifen-related uterine carcinosarcomas occur under/after prolonged treatment: Report of five cases and review of the literatureInternational Journal of Gynecologic Cancer, 2002
- Differential Regulation and Action of Estrogen Receptors and in GH3 CellsEndocrinology, 1999
- Functional inactivation of the oestrogen receptor by the antioestrogen, ZM 182780, sensitises tumour cells to reactive oxygen speciesJournal of Endocrinology, 1999
- Differential Ligand Activation of Estrogen Receptors ERα and ERβ at AP1 SitesScience, 1997
- ERβ: Identification and characterization of a novel human estrogen receptorFEBS Letters, 1996
- Involvement of the Estrogen Receptor in the Growth Response of Pituitary Tumor Cells to Interleukin-2Biochemical and Biophysical Research Communications, 1994
- Droloxifene, a new anti-oestrogen in postmenopausal advanced breast cancer: Preliminary results of a double-blind dose-finding phase II trialEuropean Journal Of Cancer, 1992
- Review of the pharmacological properties of toremifeneJournal of Steroid Biochemistry, 1990